ArticleAdvances in therapy2022

Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL).

Hideaki Kaneto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.